Green light for cannabis re­search

Canning Gazette - - NEWS -

CURTIN Uni­ver­sity is team­ing up with a lo­cal com­pany to de­velop a range of new medic­i­nal cannabis prod­ucts with the po­ten­tial to de­liver more ac­cu­rate and tar­geted treat­ment for a range of med­i­cal con­di­tions.

Curtin has pro­vided an ex­clu­sive world­wide li­cence to Lit­tle Green Pharma for the mi­cro-drug de­liv­ery sys­tem Arise (Atomised Rapid In­jec­tion for Sol­vent Ex­trac­tion. It will use raw cannabis ex­tract, pro­vided by Lit­tle Green Pharma, in an 18-month de­vel­op­ment pro­gram to gen­er­ate new medic­i­nal cannabis for­mu­la­tions.

Arise de­vel­oper and John Curtin Dis­tin­guished Emer­i­tus Pro­fes­sor Neil Fos­ter said the tech­nol­ogy had the po­ten­tial to de­liver medic­i­nal cannabis into a pa­tient’s blood­stream more quickly and ef­fi­ciently.

“Arise is a su­per­crit­i­cal anti-sol­vent ex­trac­tion tech­nol­ogy which can po­ten­tially re-en­gi­neer the ac­tive phar­ma­ceu­ti­cal in­gre­di­ents within cannabis into mi­cro par­ti­cles, mean­ing they can po­ten­tially be more eas­ily ab­sorbed into the blood­stream than con­ven­tional forms of the medic­i­nal drug,” Prof Fos­ter, from Western Aus­tralian

School of Mines: Min­er­als, En­ergy and Chem­i­cal En­gi­neer­ing, said.

“Bet­ter ab­sorp­tion means pa­tients could po­ten­tially ben­e­fit by be­ing pre­scribed lower doses for the same ther­a­peu­tic ef­fect.”

Lit­tle Green Pharma head of re­search and in­no­va­tion Leon Warne said it was an ex­cit­ing op­por­tu­nity for Aus­tralia’s first lo­cally grown medic­i­nal cannabis pro­ducer.

“Arise has the po­ten­tial to sig­nif­i­cantly im­prove the ac­cu­racy of de­liv­ery and easeof-dos­ing for pa­tients pre­scribed medic­i­nal cannabis,” Dr Warne said.

Pro­fes­sor Neil Fos­ter and Dr Leon Warne.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.